Alkermes (ALKS) Payables (2011 - 2026)
Alkermes' (ALKS) quarterly Payables came in at $332.5 million in Q2 2026, up 35.29% year-over-year from $245.7 million in Q2 2025, and up 13.63% quarter-over-quarter from $292.6 million in Q1 2026.
Analysis
Alkermes (ALKS) Payables (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Payables for 16 consecutive years, with $332.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Payables rose 35.29% year-over-year to $332.5 million in Q2 2026; TTM through Jun 2026 was $332.5 million, a 35.29% increase from a year earlier, with the FY2025 full-year figure at $289.6 million, up 56.24% from the prior year.
- Payables was $332.5 million for Q2 2026 at Alkermes, up from $292.6 million in the prior quarter.
- Over five years, Payables peaked at $332.5 million in Q2 2026 and troughed at $160.2 million in Q3 2024.
- A 5-year average of $225.6 million and a median of $217.5 million in 2022 frame the typical range for Payables.
- Across the five-year window, Payables plunged 50.66% in 2022 and soared 57.27% in 2026, its largest moves.
- Over 5 years, Payables stood at $220.1 million in 2022, then increased by 9.3% to $240.6 million in 2023, then dropped by 22.96% to $185.3 million in 2024, then jumped by 56.24% to $289.6 million in 2025, then advanced by 14.82% to $332.5 million in 2026.
- The last three Payables figures came in at $332.5 million (Q2 2026), $292.6 million (Q1 2026), and $289.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.24 Bn | 625.48 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 441.52 Bn | 434.96 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 365.75 Bn | 358.60 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 266.61 Bn | 258.92 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn | 7.03 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 8.31 Bn |
| 7 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 88.42 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 250.40 Mn |
| 9 | United Therapeutics | 21.43 Bn | 18.77 Bn | 683.80 Mn | 497.80 Mn |
| 10 | Alkermes | 7.56 Bn | 6.90 Bn | 397.90 Mn | 332.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 332.47 Mn |
| Mar 31, 2026 | 292.58 Mn |
| Dec 31, 2025 | 289.57 Mn |
| Sep 30, 2025 | 214.99 Mn |
| Jun 30, 2025 | 245.75 Mn |
| Mar 31, 2025 | 186.04 Mn |
| Dec 31, 2024 | 185.33 Mn |
| Sep 30, 2024 | 160.20 Mn |
| Jun 30, 2024 | 239.77 Mn |
| Mar 31, 2024 | 205.85 Mn |
| Dec 31, 2023 | 240.56 Mn |
| Sep 30, 2023 | 243.26 Mn |
| Jun 30, 2023 | 242.92 Mn |
| Mar 31, 2023 | 190.15 Mn |
| Dec 31, 2022 | 220.09 Mn |
| Sep 30, 2022 | 211.18 Mn |
| Jun 30, 2022 | 186.81 Mn |
| Mar 31, 2022 | 173.13 Mn |
| Dec 31, 2021 | 208.49 Mn |
| Sep 30, 2021 | 428.03 Mn |